Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|April 21, 2016

BMS Selects Medidata Clinical Cloud

Bristol-Myers Squibb will integrate a full suite of Medidata solutions, including Medidata Rave for electronic data capture, management and reporting and Medidata’s RBM solutions, Medidata TSDV and Medidata CSA, into all stages of its drug development process. Medidata has selected Accenture to be its partner for specific elements of the transformation project, which is being accomplished in a phased rollout.

Read the full release here


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.